(March 31) Linn Hemberg, an environmental science researcher in perioperative and intensive care, defended her thesis, "Critical Care, Critical Emissions: Applying life cycle assessment on intensive and perioperative care," on March 30, 2026. As one of the many talented members of the REDUSE clinical trial group, Dr. Hemberg has lent her expertise in environmental sustainability--one of the key outcomes of the REDUSE study. Using life cycle assessment to examine the environme

(March 20) This month, Malar Hospital in Eskilstuna became the most recent site to start patient recruitment for the REDUSE clinical trial. Malar Hospital (Mälarsjukhuset) is part of Region Sörmland's healthcare network and its largest hospital, providing care primarily for the county's nearly 140,000 northern residents. Malar Hospital houses a comprehensive range of in-patient wards and outpatient clinics--some jointly with Kullbergska Hospital in Katrineholm. The REDUSE tea

(March 19) The REDUSE trial is proud to acknowledge a doctoral dissertation to be generated by one of its group members: on March 13, 2026, Dr. Maria Lengquist, MD, a specialist in anesthesiology and intensive care medicine, successfully defended her thesis, entitled "Identifying Sepsis and Infections in the Intensive Care Unit." This body of work examined the fidelity with which current methods accurately diagnose sepsis and infections in intensive care unit (ICU) patients,

(March 4) Östra sjukhuset in Gothenburg is the latest hospital to begin recruiting patients into the REDUSE clinical trial. As part of Sahlgrenska University Hospital, with whom it merged in 1997, Östra sjukhuset serves the Västra Götaland region and is expanding rapidly to meet the growing healthcare needs of this area. Notably, Östra sjukhuset houses the Queen Silvia Children's Hospital, as well as recent additions to its facilities, including newly built psychiatry and add

(February 17) The REDUSE trial has begun recruiting patients at Helsinki University Hospital, Finland's largest university hospital and part of Finland's biggest healthcare network. This step marks an important milestone, representing its first inclusion of patients at an international study site. Helsinki University Hospital is engaged in specialized healthcare and clinical research and acts as a central hub for the treatment of rare and severe diseases. Its heavy investment

(December 8) The REDUSE trial recently recruited its 600th patient, constituting another significant achievement in its pursuit of improving treatment for patients with septic shock. With this milestone, this international, randomized study continues to enjoy steady enrollment of trial participants toward its recruitment target, placing the trial recruitment slightly ahead of the planned schedule. The REDUSE team is grateful to all participating patients, healthcare professio

(November 18) Norrtälje Hospital, Stockholm County's northernmost emergency hospital, is the latest site to begin recruiting patients for the REDUSE clinical trial. Norrtälje Hospital boasts round-the-clock emergency care, with its own ICU, x-ray department, helipad, and surgery department. Because of its smaller organizational structure, this countryside hospital consistently provides efficient care and rates high in patient and employee satisfaction. Previously touted as th

(November 7) Stockholm South General Hospital (Södersjukhuset; SÖS), which houses Scandinavia's largest emergency department, has begun recruiting patients for REDUSE. As one of the largest district general hospitals in the Stockholm region, SÖS specializes in major public diseases, administering and performing high-quality healthcare, education, and research. The contribution of SÖS to the REDUSE trial is part of its strong commitment toward promoting collaboration to improv

(October 13) On October 7-8, 2025, the REDUSE trial investigators, assessors, and trial management team met in Lund, Sweden, to gather in person and learn from each other through inspiring and informative presentations. For a clinical trial of the size of REDUSE, comprising over 20 sites throughout 3 countries, the opportunity to meet face to face is an important way to build connections and enthusiasm among the trial team. This 2-day-long meeting covered a wide array of topi

(October 1) Danderyd Hospital (Danderyds sjukhus), one of Sweden’s largest emergency hospitals, has now started recruiting patients for...

(September 23) Örebro University Hospital (Örebro Universitetssjukhus), part of Sweden’s newest medical school program, has officially...

The protocol for the REDUSE clinical trial was recently published in the August 2025 issue of Acta Anaesthesiologica Scandinavica. The...

Today the REDUSE trial reached a major milestone by randomizing its 400th patient. This achievement represents another important step...

Helsingborg Hospital has become the first hospital to collect biobank samples as part of the REDUSE trial.

(December 16) Varberg Hospital (Hallands Sjukhus Varberg) has officially started recruiting patients for the REDUSE trial. Located in the...

(December 11) Falun Hospital has officially begun recruiting patients for the REDUSE trial.

(November 25) On November 23rd, the REDUSE trial reached a significant milestone, randomizing its 200th patient in Sweden. This...

(November 11) The University Hospital of Umeå has started recruiting patients for the REDUSE study.

(November 6) Sahlgrenska University Hospital has started recruiting patients for the REDUSE trial.

The results of the REDUSE feasibility trial were published today in Critical Care. Read the full article here.